FDA Approved: CANASA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved Allergan's supplemental application for CANASA (mesalamine), indicating a regulatory action to update or expand the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis
• Ulcerative Proctitis

Drugs mentioned

• CANASA (Mesalamine)

Snippet

SUPPL AP for CANASA (MESALAMINE)